Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Lanepitant not effective in migraine

March 18, 1997

Pharmacodynamics and safety of the dopamine agonist CI-1007

March 18, 1997

Topical anesthesia with liposome-encapsulated tetracaine

March 18, 1997

Neuroprotective, analgesic and antitussive agents from Toray

March 18, 1997

Aricept cleared for marketing in U.K.

March 17, 1997

New therapy for essential tremor recommended for approval

March 17, 1997

SIB-1508Y associated with improvement in cognitive deficits in Parkinson's model

March 17, 1997

Repeated IVIg for relapsing-remitting MS

March 17, 1997

First approval for Zomig; antimigraine agents in development

March 14, 1997

Substance P antagonists described by Pfizer

March 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...